Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CCNC | P24863 | 1/20 | 0.39 |
| ▸ | CDK8 | P49336 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4282512 | 0.86 | HCRTR2 (0.47) | SLC6A3SLC6A4SLC6A2KMT2A | |
| SCHEMBL4291624 | 0.86 | HCRTR2 (0.42) | — | |
| SCHEMBL4291883 | 0.84 | SLC6A3 (0.46) | SLC6A3SLC6A4SLC6A2KMT2A | |
| SCHEMBL4280120 | 0.84 | LMNA (0.40) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4282256 | 0.83 | HCRTR2 (0.43) | — | |
| SCHEMBL4292811 | 0.81 | SLC6A4 (0.51) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4288939 | 0.80 | TSHR (0.44) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4285849 | 0.79 | SLC6A4 (0.47) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4294072 | 0.78 | CHRNB4 (0.41) | KMT2A | |
| SCHEMBL4285491 | 0.77 | KMT2A (0.41) | SLC6A3SLC6A4SLC6A2NR3C2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009072643-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-11 | — | — | WO | disclosed |